ALPS Medical Breakthroughs ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.50
資產淨值: 51.95
成立日期: 30/12/2014
 
分析
市值分佈:
41.79%
大市值
46.29%
中市值
10.74%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:58) 總持有投資項目: 86  
0%
 
100%
     10大 (30.47%)
代號 名稱 佔比% 持有日期
IMCRImmunocore Holdings plc1.0527/02/2026
SIONSionna Therapeutics Inc1.0527/02/2026
PVLAPalvella Therapeutics Inc1.0327/02/2026
MBXMBX Biosciences Inc.0.9427/02/2026
ZBIOZenas Biopharma Inc.0.9127/02/2026
IMTXImmatics NV0.9027/02/2026
RAPPRapport Therapeutics Inc.0.8927/02/2026
CRVSCorvus Pharmaceuticals0.8827/02/2026
TSHATaysha Gene Therapies0.8027/02/2026
MLTXMoonLake Immunotherapeutics0.8027/02/2026
DAWNDay One Biopharmaceuticals0.7027/02/2026
GERNGeron Corp0.6927/02/2026
MNKDMannKind Corp0.6527/02/2026
CMPXCompass Therapeutics0.6527/02/2026
AVBPArriVent BioPharma0.6127/02/2026
TBPHTheravance Biopharma0.6027/02/2026
BCAXBicara Therapeutics Inc.0.5927/02/2026
SPRYARS Pharmaceuticals0.5927/02/2026
XNCRXencor0.5927/02/2026
ICVX0.5331/01/2024
  1    2   3    4    5  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.